Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI), a clinical-stage biopharmaceutical company focused on developing novel therapies for prostate cancer and other hormonally driven diseases, today announced that Jodie Morrison, president and chief executive officer, will provide a company overview at two November investment conferences:
•2014 Credit Suisse Healthcare Conference in Phoenix, Arizona, on Tuesday, November
Help employers find you! Check out all the jobs and post your resume.
